23583-21-3Relevant articles and documents
Metal-organic framework MOF-199 as an efficient heterogeneous catalyst for the aza-Michael reaction
Nguyen, Lien T.L.,Nguyen, Tung T.,Nguyen, Khoa D.,Phan, Nam T.S.
, p. 44 - 52 (2012)
A highly porous metal-organic framework (MOF-199) was synthesized from the reaction of copper nitrate trihydrate and 1,3,5-benzenetricarboxylic acid by solvothermal method, and used as a recyclable acid catalyst for the aza-Michael reaction. Physical characterizations of the solid catalyst were achieved by using a variety of different techniques, including X-ray powder diffraction (XRD), scanning electron microscope (SEM), transmission electron microscopy (TEM), thermogravimetric analysis (TGA), Fourier transform infrared (FT-IR), dynamic laser light scattering (DLS), atomic absorption spectrophotometry (AAS), and nitrogen physisorption measurements. Excellent conversions were achieved under mild conditions in the presence of 5 mol% catalyst. The MOF-199 catalyst could be reused several times without a significant degradation in catalytic activity. No contribution from homogeneous catalysis of active species leaching into the liquid phase was detected.
-
Stork,McElvain
, p. 971 (1947)
-
Oxindole spiro-tetrahydrofuran compound as well as preparation method and application thereof
-
Paragraph 0030; 0034; 0039-0040; 0044; 0045, (2020/04/29)
The invention provides an indole tetrahydrofuran oxide compound or a crystal form thereof, wherein the indole tetrahydrofuran oxide compound is as shown in a formula (I). R1 is selected from benzene rings, naphthalene rings and thiophene rings or cinnamyl, R2 is selected from H, F, Cl, Br and I or C1-3 alkoxy, R3 is selected from H and benzyl or C1-C3 alkyl, and R4 is H, F, Cl, Br, I and C1-3 alkoxy or C1-C3 alkyl. The invention further provides a method for preparing the compound. The compound is simple and convenient in preparation method, moderate in reaction and high in yield and has anti-tumor activity and a wide market application prospect.
3-AMINO-2-[2-(ACYLAMINO)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE AS CSNK1 INHIBITORS
-
Page/Page column 114, (2020/08/22)
Compounds of formula (I), processes for their production and their use as pharmaceuticals. The compounds are inhibitors of Casein kinase 1 alpha and/or delta ( CSNK1α and/or 6) useful for the treatment of proliferative disorders. (l)